Which has the lower trailing P/E, LH or WST?

LH has the lower trailing P/E: LH trades at 26.58 and WST at 45.03. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, LH or WST?

Over the past five years, WST grew revenue faster — LH at a -2.62% CAGR versus WST at 5.68%.

Does LH or WST pay a bigger dividend?

LH yields 0.90% and WST yields 0.25% based on trailing dividends and the latest price.

Is LH or WST more profitable?

WST runs the higher net margin — LH at 6.99% versus WST at 16.98%.

How have LH and WST total returns compared?

Over the past 10 years, LH delivered 10.88% and WST delivered 16.17% annualized total return. Past performance doesn't predict future results.

Labcorp Holdings Inc. (LH) vs West Pharmaceutical Services, Inc. (WST)

A side-by-side comparison of Labcorp Holdings Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 11, 2026. Differences are shown without an overall score or investment verdict.

Labcorp Holdings Inc.

$26.44B

$322.42HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

WST

West Pharmaceutical Services, Inc.

$24.73B

$351.37HealthcareDelayed quote: Aug 11, 2026, 4:02 PM EDT

Total return — LH vs WST

growth of $100 · dividends reinvested · last 10y

LH +181.3% (+10.9%/yr)WST +350.9% (+16.3%/yr)WST compounded faster over this window

LH WST

LH vs WST: by the numbers

•LH is the larger company ($26.44B vs $24.73B market cap).
•LH trades at the lower trailing earnings multiple (26.58 vs 45.03 P/E), one valuation lens rather than an overall verdict.
•WST converts more revenue to profit (16.98% vs 6.99% net margin).
•WST grew revenue faster over the past five years (5.68% vs -2.62% CAGR).
•LH pays the higher dividend yield (0.90% vs 0.25%).

Metrics side by side

Valuation

Metric	LH	WST
P/E ratio	26.58	45.03
Forward P/E	17.60	39.38
P/S ratio	1.84	7.55
P/B ratio	3.06	8.40
EV / EBITDA	14.25	28.82
FCF yield	4.38%	1.74%

Profitability

Metric	LH	WST
Gross margin	27.85%	36.77%
Operating margin	11.27%	20.64%
Net margin	6.99%	16.98%
ROE	11.65%	18.89%
ROIC	7.39%	13.62%

Dividends

Metric	LH	WST
Dividend yield	0.90%	0.25%
Payout ratio	27.32%	12.88%

Growth (annualized)

Metric	LH	WST
Revenue CAGR (5Y)	-2.62%	5.68%
EPS CAGR (5Y)	-8.00%	7.85%
FCF CAGR (5Y)	-16.45%	8.74%
Total return CAGR (5Y)	5.47%	-3.44%

Frequently asked

Which has the lower trailing P/E, LH or WST?: LH has the lower trailing P/E: LH trades at 26.58 and WST at 45.03. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, LH or WST?: Over the past five years, WST grew revenue faster — LH at a -2.62% CAGR versus WST at 5.68%.
Does LH or WST pay a bigger dividend?: LH yields 0.90% and WST yields 0.25% based on trailing dividends and the latest price.
Is LH or WST more profitable?: WST runs the higher net margin — LH at 6.99% versus WST at 16.98%.
How have LH and WST total returns compared?: Over the past 10 years, LH delivered 10.88% and WST delivered 16.17% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LH analysis Full WST analysis Interactive comparison tool

Dig into the metrics

Labcorp P/E ratio West Pharmaceutical Services P/E ratio Labcorp dividend yield West Pharmaceutical Services dividend yield Labcorp ROE West Pharmaceutical Services ROE Labcorp operating margin West Pharmaceutical Services operating margin Labcorp revenue growth West Pharmaceutical Services revenue growth Labcorp free cash flow West Pharmaceutical Services free cash flow

Labcorp & West Pharmaceutical Services appear in these rankings

25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 11, 2026.